Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 227,008,050 papers from all fields of science
Search
Sign In
Create Free Account
Vulvovaginal atrophy
National Institutes of Health
Create Alert
Alert
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Experience with ospemifene in patients with vulvovaginal atrophy treated with laser therapy: case studies
Félix Lugo Salcedo
,
Zuramis Estrada Blanco
Drugs in Context
2020
Corpus ID: 220333669
Vaginal laser therapy is a non-hormonal treatment option for vulvovaginal atrophy (VVA), a component of the genitourinary…
Expand
Review
2019
Review
2019
Clinician knowledge, attitudes, and barriers to management of vulvovaginal atrophy: variations in primary care and gynecology
K. Vesco
,
Kate Beadle
,
Ashley B. Stoneburner
,
J. Bulkley
,
M. Leo
,
Amanda L. Clark
Menopause
2019
Corpus ID: 52111642
Objective: Vulvovaginal atrophy is a common, but under-recognized condition affecting postmenopausal women. To guide development…
Expand
Review
2017
Review
2017
Vulvovaginal Issues in Mature Women
M. Marnach
,
R. Torgerson
Mayo Clinic proceedings
2017
Corpus ID: 206807562
2017
2017
A low dose (6.5 mg) of intravaginal DHEA permits a strictly local action while maintaining all serum estrogens or androgens as well as their metabolites within normal values
F. Labrie
,
C. Martel
Hormone Molecular Biology and Clinical…
2017
Corpus ID: 26450865
Abstract Objective: Serum concentrations of estradiol (E2) and testosterone (testo) measured by mass spectrometry-based assays…
Expand
2017
2017
Concentration range of serum sex steroids in normal postmenopausal women and those with diagnosis of vulvovaginal atrophy
Yuyong Ke
,
A. Bélanger
,
+4 authors
F. Labrie
Menopause
2017
Corpus ID: 3442835
Objective: The aim of the study was to determine the range of serum sex-related steroids in normal postmenopausal women and in…
Expand
Review
2017
Review
2017
Laser treatment in urogynaecology and the myth of the scientific evidence
G. Digesu
,
S. Swift
International Urogynecology Journal
2017
Corpus ID: 3964466
In 2015, we published an editorial in the International Urogynecology Journal on laser vaginal rejuvenation [1]. We questioned…
Expand
2015
2015
Œstrogénothérapie locale en urologie et pelvi-périnéologie. Revue de littérature.
T. Benoit
,
P. Leguevaque
,
+7 authors
X. Gamé
2015
Corpus ID: 116029681
Review
2014
Review
2014
Ospemifene in the Treatment of Vulvovaginal Atrophy
Kylie N. Barnes
,
Erica F. Pearce
,
Abigail M. Yancey
,
Alicia B. Forinash
The Annals of Pharmacotherapy
2014
Corpus ID: 2757393
Objective: To review the pharmacology, efficacy, and safety of ospemifene in the management of dyspareunia. Data Sources…
Expand
2011
2011
Vulvovaginal atrophy: a common--and commonly overlooked--problem.
M. Hohenhaus
Medicine and health, Rhode Island
2011
Corpus ID: 30300812
Mrs. K is a 67-year-old woman presenting for a brief follow-up visit. You treated her for an E. coli urinary tract infection last…
Expand
Review
2001
Review
2001
Menopause and Sexual Function
G. Graves
,
R. Lea
,
G. Bourgeois‐Law
2001
Corpus ID: 148388593
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE
or Only Accept Required